Clinical trial
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase…
NCT00108511 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00108511 |
|---|---|
| Title | Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides |
| Official title | Effect of Gemfibrozil on Serum GPI Phospholipase D and Triglycerides |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | Gemfibrozil |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2007 |
| First posted | Apr 18, 2005 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: